Hoffmann, M.; Ermler, T.F.; Hoffmann, F.; Alexa, R.; Kranz, J.; Steinke, N.; Leypold, S.; Gaisa, N.T.; Saar, M.
Therapeutic and Diagnostic Potential of Folic Acid Receptors and Glycosylphosphatidylinositol (GPI) Transamidase in Prostate Cancer. Cancers 2024, 16, 2008.
https://doi.org/10.3390/cancers16112008
AMA Style
Hoffmann M, Ermler TF, Hoffmann F, Alexa R, Kranz J, Steinke N, Leypold S, Gaisa NT, Saar M.
Therapeutic and Diagnostic Potential of Folic Acid Receptors and Glycosylphosphatidylinositol (GPI) Transamidase in Prostate Cancer. Cancers. 2024; 16(11):2008.
https://doi.org/10.3390/cancers16112008
Chicago/Turabian Style
Hoffmann, Marco, Thomas Frank Ermler, Felix Hoffmann, Radu Alexa, Jennifer Kranz, Nathalie Steinke, Sophie Leypold, Nadine Therese Gaisa, and Matthias Saar.
2024. "Therapeutic and Diagnostic Potential of Folic Acid Receptors and Glycosylphosphatidylinositol (GPI) Transamidase in Prostate Cancer" Cancers 16, no. 11: 2008.
https://doi.org/10.3390/cancers16112008
APA Style
Hoffmann, M., Ermler, T. F., Hoffmann, F., Alexa, R., Kranz, J., Steinke, N., Leypold, S., Gaisa, N. T., & Saar, M.
(2024). Therapeutic and Diagnostic Potential of Folic Acid Receptors and Glycosylphosphatidylinositol (GPI) Transamidase in Prostate Cancer. Cancers, 16(11), 2008.
https://doi.org/10.3390/cancers16112008